scholarly journals Randomized Phase Ii Study of S-1 Plus Oral Leucovorin (Sl) Versus Sl Plus Oxaliplatin (Sol) Versus S-1 Plus Cisplatin (Sp) in Patients with Advanced Gastric Cancer (Agc):Updated Overall Survival Data

2014 ◽  
Vol 25 ◽  
pp. iv213 ◽  
Author(s):  
K. Yamaguchi ◽  
S. Hironaka ◽  
N. Sugimoto ◽  
T. Moriwaki ◽  
Y. Komatsu ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Overall Survival ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Survival Data ◽  
Phase Ii Study ◽  
Randomized Phase Ii

scholarly journals Randomized Phase II Study of CPT-11 vs PTX; +/- S1 in Advanced Gastric Cancer Refractory to S1 or S1 + Platinum

2014 ◽  
Vol 25 ◽  
pp. ii28
Author(s):  
Goto Masahiro ◽  
Imamura Hiroshi ◽  
Kawase Tomono ◽  
Kimura Yutaka ◽  
Ueda Shugo ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Randomized Phase Ii

Pazopanib and 5-FU/oxaliplatin as first-line treatment in advanced gastric cancer: PaFLO, a randomized phase II study from the AIO (Arbeitsgemeinschaft Internistische Onkologie).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 4033-4033 ◽  
Author(s):  
Peter C. Thuss-Patience ◽  
Salah-Eddin Al-Batran ◽  
Jens T Siveke ◽  
Nils Homann ◽  
Peter Malfertheiner ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Line Treatment ◽  
First Line ◽  
Randomized Phase Ii ◽  
First Line Treatment

scholarly journals Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003)

2017 ◽  
Vol 22 (6) ◽  
pp. 1052-1059 ◽  
Author(s):  
Hiroaki Tanaka ◽  
Mitsuro Kanda ◽  
Satoshi Morita ◽  
Masataka Taguri ◽  
Kazuhiro Nishikawa ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document